Document and Entity Information
Document and Entity Information | Oct. 08, 2020 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001720725 |
Document Type | 8-K |
Document Period End Date | Oct. 8, 2020 |
Entity Registrant Name | Oyster Point Pharma, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39112 |
Entity Tax Identification Number | 81-1030955 |
Entity Address, Address Line One | 202 Carnegie Center |
Entity Address, Address Line Two | Suite 109 |
Entity Address, City or Town | Princeton |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 08540 |
City Area Code | (609) |
Local Phone Number | 382-9032 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.001 per share |
Trading Symbol | OYST |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |